US equities
|
MU
$856.49
▲+0.00%
SPCX
$144.75
▲+0.00%
SNDK
$1,260.93
▲+0.00%
NVDA
$212.21
▲+0.00%
ELME
$1.77
▲+5800.00%
BE
$217.77
▲+0.00%
TSLA
$374.57
▼-0.00%
WDC
$354.19
▲+0.00%
MU
$856.49
▲+0.00%
SPCX
$144.75
▲+0.00%
SNDK
$1,260.93
▲+0.00%
NVDA
$212.21
▲+0.00%
ELME
$1.77
▲+5800.00%
BE
$217.77
▲+0.00%
TSLA
$374.57
▼-0.00%
WDC
$354.19
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Quantum BioPharma Ltd.
Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
September 11, 2026
From
Quantum BioPharma Ltd.
Via
GlobeNewswire
Tickers
CSE:QNTM
QNTM
Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment
September 09, 2026
From
Quantum BioPharma Ltd.
Via
GlobeNewswire
Tickers
CSE:QNTM
QNTM
Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy
June 25, 2026
From
Quantum BioPharma Ltd.
Via
GlobeNewswire
Tickers
CSE:QNTM
QNTM
Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach
June 23, 2026
From
Quantum BioPharma Ltd.
Via
GlobeNewswire
Tickers
CSE:QNTM
QNTM